IPA Workshops at Up-Coming Congress
Workshop 1 - Educational Program: Young-Onset Dementias - For Young Physicians and Multi-Disciplinary Professionals
Wednesday, 24 September, 2:00-5:30 PM
$50.00 USD
Target audience: Early-career physicians and medical staff working in the field of dementia
This program aims to provide basic knowledge and practical strategies for the management and care of individuals with rare dementias, particularly posterior cortical atrophy (PCA) and frontotemporal dementia (FTD). These neurodegenerative conditions are characterized by prominent impairments in visuospatial functions, language, and behavior, rather than memory deficits, which are more typical of Alzheimer’s disease (AD). As most patients with PCA and FTD are young-onset, conventional dementia support systems are often insufficient. There is thus a critical need for individualized, symptom-focused support systems that address the unique challenges faced by these patients and their families.
Program Goals:
- To acquire basic understanding of the clinical presentations and neuroimaging profiles of PCA and FTD
- To learn practical approaches to the management of and care for patients with PCA and FTD, as well as their families, in real-world settings
Course details
Format: In-person, paid course
Duration: Approximately 4 hours (including discussion)
Organizers: Maki Suzuki (The University of Osaka, Japan) and Sebastian Crutch (University College London, UK)
Number of participants: Approximately 50
Session Structure: Interactive feedback and evaluation will be collected throughout the sessions to explore changes in audience knowledge and attitudes, and gather ideas regarding the development of dementia support services
Lectures
Posterior cortical atrophy (PCA)
Clinical Introduction: Sebastian Crutch (University College London, UK)
Care Approaches and Environmental Strategies: Maki Suzuki (The University of Osaka, Japan)
Clinical Introduction: 40 minutes lecture+10 minutes Q&A
Care Approaches and Environmental Strategies: 30 minutes lecture+10 minutes Q&A
Frontotemporal dementia (FTD)
Clinical Introduction: Manabu Ikeda (The University of Osaka, Japan)
Care Approaches and Environmental Strategies: Eneida Mioshi (University of East Anglia, UK)
Clinical Introduction: 40 minutes lecture+10 minutes Q&A
Care Approaches and Environmental Strategies: 30 minutes lecture+10 minutes Q&A
Patient and family support systems
Nikki Zimmermann (Rare Dementia Support, UK)
Introduce 2 representative cases and discuss the cases with all speakers involved
30 minutes lecture + 10 minutes Q&A
 |
Title: ‘Clinical Introduction to Posterior Cortical Atrophy (PCA)’ Professor Sebastian Crutch Professor of Neuropsychology, Dementia Research Centre, University College London, UK Seb Crutch is a Professor of Neuropsychology and clinical psychologist at UCL, and has been the clinical lead for RDS since its inception in 2016, leading the expansion from large support groups to more intimate small group and one-to-one services. Like his clinical and support work practice, much of Seb’s research – especially into visual forms of dementia – has been inspired by the voices of those living with these conditions, including the Created Out of Mind dementia, science and arts residency he directed at Wellcome Collection, and the current five-year ESRC-NIHR-funded research programme evaluating the impact of support groups that bring together peer and professional experience. |
 |
Title: ‘Care Approaches and Environmental Strategies for Posterior Cortical Atrophy (PCA)’ Dr. Maki Suzuki Associate professor of Department of Behavioral Neurology and Neuropsychiatry, The University of Osaka United Graduate School of Child Development, Japan Maki Suzuki is an Associate Professor of Department of Behavioral Neurology and Neuropsychiatry and a neuropsychologist at the University of Osaka. She serves as a councilor of the Neuropsychology Association of Japan and the Japanese Society of Geriatric Psychiatry. Her research employs neuropsychological assessments and neuroimaging techniques to investigate the cognitive underpinnings of human behavior in both healthy adults and individuals with neurodegenerative diseases, with a particular focus on posterior cortical atrophy and frontotemporal dementia. |
  |
Title: ‘Clinical Introduction to Frontotemporal Dementia (FTD)’ Professor Manabu Ikeda Professor of Department of Psychiatry, The University of Osaka Graduate School of Medicine, Japan Manabu Ikeda is a Chairman and Professor of Department of Psychiatry at the University of Osaka. He serves on the boards of numerous academic societies, including the Neuropsychology Association of Japan, the Japanese Society of Dementia Research, the Japanese Society of Psychiatry and Neurology, the Asian Society Against Dementia, and the International Psychogeriatric Association. With a background in neuropsychiatry, neuropsychology, and old age psychiatry, his research encompasses a broad range of topics within clinical neuropsychiatry. |
 |
Title: ‘Care Approaches and Environmental Strategies for Frontotemporal Dementia (FTD)’ |
 |
Title: ‘Support Systems for Patients and Families Living with Rare Dementias’ Nikki Zimmermann Head of Support Services, Rare Dementia Support, UK Nikki Zimmermann is the Head of Support Services for RDS and manages the direct support team of support workers and advisers. With over ten years’ experience working in cognitive neurology clinics and memory services, Nikki is an expert in service development and delivery within a variety of health and social care and community settings. Nikki specializes in pre-diagnosis navigation and post-diagnostic support, and is passionate about the role the new centre can play in enhancing the knowledge and understanding of health and social care professionals to enable them to better support people living with rare dementia and their families. |
Workshop 2 - Educational Program: Latest Knowledge Useful for Dementia Diagnosis and Treatments - For Physicians
Wednesday, 24 September, 2:00-5:30 PM
$50.00 USD
Target audience: Early-career physicians and medical staff working in the field of dementia
This program is designed to provide participants with up-to-date knowledge essential for current dementia care, including neuroimaging, anti-amyloid β (Aβ) monoclonal antibody therapies, and both pharmacological and non-pharmacological interventions for behavioral and psychological symptoms of dementia (BPSD). The diagnosis and treatment of dementia have entered a new era with the introduction of anti-Aβ antibody therapies for Alzheimer's disease. An increasing number of patients are seeking medical attention at earlier stages, making neuroimaging more critical than ever. For eligible patients, it is essential to administer anti-Aβ antibody treatments appropriately and safely, which requires a restructuring of regional healthcare systems. In addition, the importance of preventive measures and early interventions for BPSD is growing, emphasizing the need for evidence-based pharmacological and non-pharmacological therapies.
Program Goals:
- To acquire knowledge on the appropriate selection and interpretation of neuroimaging studies essential for current dementia care, and how to apply these findings in clinical practice.
- To learn the fundamentals and practical implementation of anti-Aβ antibody therapies.
- To understand the latest evidence on pharmacological and non-pharmacological interventions for BPSD.
Course Details:
Format: In-person, paid course
Duration: Approximately 4 hours (including discussion)
Organizers: Hiroaki Kazui (Kochi University, Japan)
Number of participants: Approximately 50
Session Structure: For each topic, the session will begin with a lecture presenting the latest knowledge and developments. This will be followed by interactive discussions between the speakers and participants to deepen understanding and promote active exchange of ideas.
Lectures
Neuroimaging findings useful for dementia diagnosis
Etsuro Mori (Osaka University, Japan)
45 minutes lecture+15 minutes Q&A
Anti-amyloid beta antibody therapy
Kenjiro Ono (Kanazawa University, Japan)
45 minutes lecture+15 minutes Q&A
Pharmacological treatments for BPSD
Shunichiro Shinagawa (Jikei University, Japan)
45 minutes lecture+15 minutes Q&A
Non-pharmacological Interventions for BPSD
Hiroaki Kazui (Kochi University, Japan)
45 minutes lecture+15 minutes Q&A
 |
Title: ‘Neuroimaging findings useful for dementia diagnosis’ Professor Etsuro Mori Professor of Department of Behavioral Neurology and Neuropsychiatry, The University of Osaka United Graduate School of Child Development, Japan Prof. Etsuro Mori is one of the leading figures in dementia care and research in Japan, with particular expertise in neuroimaging. The DESH finding in idiopathic normal pressure hydrocephalus, which Prof. Mori named and introduced to the world, has now become the knowledge in both structural and functional neuroimaging, Prof. Mori will provide comprehensive instruction on the appropriate selection and interpretation of neuroimaging studies essential for current dementia care, and on how to apply these findings in clinical practice. |
 |
Title: ‘Anti-amyloid beta monoclonal antibody therapy’ Professor Kenjiro Ono Professor of Department of Neurology Kanazawa University Graduate School of Medical Science, Japan Prof. Kenjiro Ono is one of Japan’s leading neurologists specializing in dementia care. His outstanding contributions to the elucidation of Alzheimer’s disease pathology and the development of therapeutic approaches have been highly recognized both domestically and internationally. In particular, he was the first in the world to clarify the mechanism of action of the anti-Aβ antibody, lecanemab, significantly advancing our understanding of the disease-modifying effects in Alzheimer’s disease. He is the most suitable speaker to lead today’s lecture on this important topic. |
 |
Title: ‘Pharmacological treatments for BPSD’ Professor Shunichiro Shinagawa Professor of Department of Psychiatry, The Jikei University School of Medicine, Japan Prof. Shunichiro Shinagawa is a psychiatrist specializing in geriatric psychiatry and dementia, and is recognized as one of the next-generation leaders in the Japanese Society of Geriatric Psychiatry. He has conducted extensive research on BPSD, contributing significantly to the neuroanatomical understanding of BPSD. He has recently focused on the development of diagnostic biomarkers for dementia using DNA methylation and has conducted systematic reviews on pharmacological treatments for BPSD. In this lecture, he will present the latest evidence, including findings from the systematic reviews. |
 |
Title: ‘Non-pharmacological Interventions for BPSD’ Professor Hiroaki Kazui Professor of Department of Neuropsychiatry, Kochi Medical School, Kochi University, Japan Prof. Hiroaki Kazui is Vice President of the Japanese Society of Geriatric Psychiatry and has conducted extensive research on BPSD. He emphasizes the importance of prevention and early intervention in the treatment of BPSD. In this context, he has led the development and validation of an ICT-based system for collecting and analyzing dementia care practices, known as the "Circle of Wisdom for Dementia Care (Dementia Chienowa) Net," which supports the identification of good practices nationwide. In recent years, he has also conducted systematic reviews focusing on non-pharmacological interventions for BPSD. In this lecture, he will present the latest findings from these reviews. |
